BCL2 and neoplasm: The Immunohistochemical (IHC) staining of the tumour sections showed that, when compared to vehicle, SLMP53-2 decreased Ki-67, Vimentin, β-catenin, Slug and BCL-2, while increasing p53, BAX and TUNEL staining (Figure 8E–H).